Correlation Between Crinetics Pharmaceuticals and BioAffinity Technologies,
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and bioAffinity Technologies,, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and BioAffinity Technologies,.
Diversification Opportunities for Crinetics Pharmaceuticals and BioAffinity Technologies,
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Crinetics and BioAffinity is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and BioAffinity Technologies, go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and BioAffinity Technologies,
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to under-perform the BioAffinity Technologies,. But the stock apears to be less risky and, when comparing its historical volatility, Crinetics Pharmaceuticals is 1.18 times less risky than BioAffinity Technologies,. The stock trades about -0.23 of its potential returns per unit of risk. The bioAffinity Technologies, is currently generating about -0.16 of returns per unit of risk over similar time horizon. If you would invest 94.00 in bioAffinity Technologies, on November 3, 2024 and sell it today you would lose (18.00) from holding bioAffinity Technologies, or give up 19.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. bioAffinity Technologies,
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| bioAffinity Technologies, |
Crinetics Pharmaceuticals and BioAffinity Technologies, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and BioAffinity Technologies,
The main advantage of trading using opposite Crinetics Pharmaceuticals and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
| BioAffinity Technologies, vs. Intelligent Bio Solutions | BioAffinity Technologies, vs. T2 Biosystms | BioAffinity Technologies, vs. Precipio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |